Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 09, 2025 08:00 ET | Source: Cingulate Inc.

Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in the $5.5 Billion U.S. Anxiety Market, and the $11.6 Billion Anxiety Market...
September 25, 2024 08:00 ET | Source: 3Daughters

3Daughters Announces NIH to Support Testing of Novel Frameless Magnetic Copper IUD (3D-001) for Contraception

MANSFIELD, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- 3Daughters, Inc., a clinical development company fueling evolutionary healthcare for women, announced the Eunice Kennedy Shriver National...
December 04, 2023 08:40 ET | Source: Artificial Intelligence Technology Solutions, Inc.

AITX Secures $2 Million Commitment in Non-Dilutive Funding

Detroit, Michigan, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (OTCPK:AITX), a global leader in AI-driven security and productivity solutions, proudly...
August 22, 2023 06:00 ET | Source: Neuronascent, Inc.

Neuronascent Announces NIA Grant Award for NNI-362 to Reach Phase 2 Clinical Trials for Mild to Moderate Alzheimer’s Disease

ROCKVILLE, Md., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Neuronascent Inc., a privately-held neuron regeneration therapeutics company, today announced that the National Institute of Aging (NIA), has...
August 11, 2023 16:05 ET | Source: Nemaura Medical, Inc

Nemaura Medical Secures $6.5m in Non-Dilutive Funding

Loughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
May 23, 2022 06:30 ET | Source: Nemaura Medical, Inc

Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding

Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
December 15, 2020 12:52 ET | Source: Arch Biopartners

Arch Biopartners Receives Government of Canada Funding to Support Phase II Therapeutic Trial of Metablok for COVID-19

Government of Canada contribution up to $6.7 MillionFunding from the department of Innovation, Science and Economic Development through the Strategic Innovation Fund and part of the Government of...
October 01, 2019 08:00 ET | Source: Celsion CORP

Celsion Strengthens Its 2019 Balance Sheet with the Approval of Its Application to Sell Net Operating Losses for $2.1 Million in Non-Dilutive Funding

$2 Million in Additional NOL Sales are Available to the Company in 2020 Funding Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program LAWRENCEVILLE, N.J., Oct. 01,...
August 14, 2018 08:30 ET | Source: Patriot One Technologies Inc

Patriot One enters into conditional agreement in principle for technology funding with International Defence Contractor

TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc. (TSX.V: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), makers of the award-winning PATSCAN CMR covert...